Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT07091201
Active, not recruiting Observational

Validity and Reliability The Foot-taping Test in Children With Cerebral Palsy

NCT07091201 · tracked via the Priya Life Science Turkey tracker
Sponsor
Afyonkarahisar Health Sciences University
Phase
Observational
Started
2024-03-15
Last updated
2025-07-29

Condition(s) studied

Cerebral Palsy

Study summary

In spastic cerebral palsy, there are interrelated neuromuscular deficits that can affect ankle joint control, including impaired selective voluntary motor control, muscle weakness, spasticity, and shortened muscle-tendon units. As a result, it is important to assess ankle joint control in children with spastic cerebral palsy. Clinicians need valid, reliable, and practical methods to assess ankle joint control. The aim of this study is to evaluate the validity and reliability of the Foot-taping Test in children with spastic cerebral palsy.

Eligibility

Sex
ALL
Min age
6 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * ≤3 diagnosed with spastic cerebral palsy according to the Gross Motor Function and Classification System * Be between 6 and 18 years of age * Be diagnosed with spastic diplegic or spastic hemiplegic cerebral palsy * Have a GMFCS score ≤3 * Have a Communication Function Classification System (CFCS) score ≤2 * Have a Modified Ashworth Scale (MASH) score ≤3 for lower limb muscles * Be able to walk 10 metres independently * Be able to follow verbal commands Exclusion Criteria: * The presence of serious hearing, vision or cognitive problems, * The presence of nerve block injections or orthopaedic surgery within the last 6 months (such as Botox injections or muscle lengthening surgery)

Primary outcome measure(s)

  • Foot-Taping Test — Two assessors will administer the SAVT to the participants on the first day, two hours apart (first test). The duration of the test is 5 minutes. The retest will be administered 7-10 days after the first test.
    For this test, the participant will be asked to strike the floor as quickly as possible for 10 seconds with each bare foot. The number of times the participant taps their foot on the ground within 10 seconds is recorded. The higher the number of times the participant taps their foot, the better their ankle control.
  • Active Ankle Range of Motion — Two assessors will administer the SAVT to the participants on the first day, two hours apart (first test). The duration of the test is 10 minutes.
    The participant will be placed supine, and the head of the fibula, lateral malleolus, head of the fifth metatarsal, and base of the fifth metatarsal will be marked. A digital camera will be used to photograph the range of motion of active dorsiflexion and plantar flexion. ImageJ, a software, will be used to measure the ROMs from the images.

Trial sites (1)

FacilityCityRegionStatus
Department of Orthopedic Prosthesis-Orthosis, Afyonkarahisar Health Sciences University, Atatürk Health Services Vocational School Afyonkarahisar Turkey (Türkiye)

More Afyonkarahisar Health Sciences University trials in Turkey

Ultrasonograpy in Hemiplegic Patients Active, not recruiting
The Effect of Hypnosis on Periodontal Treatment Recruiting
Repetitive Transcranial Magnetic Stimulation Therapy in Spinal Cord Injury Related Neuropathic Pain Recruiting
Clinical Success of Stainless Steel Crowns Applied Using Different Cements Active, not recruiting
Comparison of Rest Splints vs High-Intensity Laser Therapy in Carpal Tunnel Syndrome Recruiting

Other trials for the same condition

Effects of Robotic Gait, Hydrotherapy, and Conventional Physiotherapy in Spastic Hemiparetic CP Starting soon
Combined Popliteal and Adductor Canal Blocks for Postoperative Analgesia in Children With Cerebral Palsy Starting soon
How Much Virtual Reality Intervention Improve the Balance of Patients With Cerebral Palsy Recruiting
Investıgatıon Of The Effectıveness Of The Mollıı Suıt In Chıldren Wıth Ambulatory Cerebral Palsy Recruiting
Sleep Quality, Caregiver Burden, Stress, and Self-Efficacy in Parents of Children With Spastic Diplegic Cerebral Palsy: A Comparison by Night Orthosis Use Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07091201 on ClinicalTrials.gov ↗ ← All trials in Turkey